Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy.
暂无分享,去创建一个
[1] Urszula Ledzewicz,et al. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy. , 2007, Mathematical biosciences.
[2] Richard Bellman,et al. Introduction to the mathematical theory of control processes , 1967 .
[3] P. Hahnfeldt,et al. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.
[4] Alberto d'Onofrio,et al. Rapidly acting antitumoral antiangiogenic therapies. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.
[5] M. I. Zelikin,et al. Theory of Chattering Control: with applications to Astronautics, Robotics, Economics, and Engineering , 1994 .
[6] U. Ledzewicz,et al. The influence of pk/pd on the structure of optimal controls in cancer chemotherapy models. , 2005, Mathematical biosciences and engineering : MBE.
[7] A. Świerniak,et al. Direct and indirect control of cancer populations , 2008 .
[8] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.
[9] J. Folkman,et al. Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.
[10] Urszula Ledzewicz,et al. OPTIMAL CONTROL FOR A CLASS OF COMPARTMENTAL MODELS IN CANCER CHEMOTHERAPY , 2003 .
[11] J. Folkman,et al. Angiogenesis Inhibitors Generated by Tumors , 1995, Molecular medicine.
[12] Urszula Ledzewicz,et al. Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis. , 2008, Journal of theoretical biology.
[13] M. Chyba,et al. Singular Trajectories and Their Role in Control Theory , 2003, IEEE Transactions on Automatic Control.
[14] Shay Soker,et al. VEGF/VPF: The angiogenesis factor found? , 1993, Current Biology.
[15] Urszula Ledzewicz,et al. No . 4 B Singular controls and chattering arcs in optimal control problems arising in biomedicine , 2010 .
[16] R. Kerbel. Tumor angiogenesis: past, present and the near future. , 2000, Carcinogenesis.
[17] H. Maurer,et al. Optimization methods for the verification of second order sufficient conditions for bang–bang controls , 2005 .
[18] Urszula Ledzewicz,et al. ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY , 2002 .
[19] Urszula Ledzewicz,et al. Optimal Bang-Bang Controls for a Two-Compartment Model in Cancer Chemotherapy , 2002 .
[20] H. Schättler,et al. A Synthesis of Optimal Controls for a Model of Tumor Growth under Angiogenic Inhibitors , 2005, Proceedings of the 44th IEEE Conference on Decision and Control.
[21] Rakesh K. Jain,et al. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.
[22] H. Schättler,et al. On optimal delivery of combination therapy for tumors. , 2009, Mathematical biosciences.
[23] R. Kerbel. A cancer therapy resistant to resistance , 1997, Nature.
[24] M. I. Zelikin,et al. The Ubiquity of Fuller’s Phenomenon , 1994 .
[25] Alberto Gandolfi,et al. A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy. , 2008, Mathematical medicine and biology : a journal of the IMA.
[26] Urszula Ledzewicz,et al. AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem , 2007, SIAM J. Control. Optim..
[27] Urszula Ledzewicz,et al. Bang-bang and singular controls in a mathematical model for combined anti-angiogenic and chemotherapy treatments , 2009, Proceedings of the 48h IEEE Conference on Decision and Control (CDC) held jointly with 2009 28th Chinese Control Conference.
[28] Alberto Gandolfi,et al. Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999). , 2004, Mathematical biosciences.
[29] L. Wein,et al. Optimal scheduling of radiotherapy and angiogenic inhibitors , 2003, Bulletin of mathematical biology.
[30] D. Wishart. Introduction to the Mathematical Theory of Control Processes. Volume 1—Linear Equations and Quadratic Criteria , 1969 .
[31] Urszula Ledzewicz,et al. Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models , 2009 .
[32] Urszula Ledzewicz,et al. Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis. , 2011, Mathematical biosciences and engineering : MBE.
[33] U. Ledzewicz,et al. ANTI-ANGIOGENIC THERAPY IN CANCER TREATMENT AS AN OPTIMAL CONTROL PROBLEM , 2007 .